Healthy Clinical Trial
Official title:
Efficacy of Mindful Tai Chi Intervention on Obese and Overweight Adults: A Randomized Controlled Clinical Trial
Background:
- New weight-loss intervention programs are being studied to determine their effectiveness
in helping overweight and obese individuals reach a healthy weight. However, these
programs often have not been tested against each other, and researchers are interested
in determining which interventions are most effective both immediately and over the long
term in promoting and maintaining weight loss.
- Mindful Tai Chi is a combined form of the meditative martial art tai chi and the
practice of mindfulness meditation. Tai chi and mindfulness meditation both have common
philosophical underpinnings that address health promotion and well-being by applying the
skill of non-judgmental awareness on a moment-to-moment daily basis. More research is
needed on whether Mindful Tai Chi and mindfulness meditation can help improve various
health factors in overweight and obese individuals.
Objectives:
- To compare the effects of Mindful Tai Chi, mindfulness meditation, walking, or a discussion
group on the weight and well being of overweight and obese participants.
Eligibility:
- Healthy individuals at least 18 years of age who are either overweight or obese (body mass
index between 25 and 40), have a sedentary lifestyle (have not engaged in more than 1 hour of
aerobic exercise per week within the last month), and are willing to commit to a specific
weight-loss intervention program.
Design:
- This study involves four visits for collecting information and 12 weeks of research
study activities.
- During the first visit, participants will hear information about the study and may ask
any questions. They will be screened with a medical history and physical examination,
and those eligible will be assigned to one of the four study groups: Mindful Tai Chi
(MTC), Mindfulness Meditation (MM), Mall Walking (MW), or Weekly Discussion (WD) group.
- For the second visit, participants will give blood and urine samples, receive an
abdominal ultrasound, ride a stationary bicycle for 5 minutes, and fill out
health-related questionnaires.
- For 12 weeks, participants will be involved in the following activities depending on
their group:
- MTC: Class for 2 hours per week, emphasizing the meditation aspects of tai chi. Each
session will include at least 20 minutes of meditation. Participants will receive
written instructions and an accompanying DVD in comparable formats specifying a minimum
of 30 minutes of daily home assignment. In weeks 2 and 8, participants will have a
workshop for mindfulness skill application in daily activity.
- MM: Class for 2 hours per week of mindfulness meditation. Participants will receive
written instructions and an accompanying DVD in comparable formats specifying a minimum
of 30 minutes of daily home assignment. In weeks 2 and 8, participants will have a
workshop for mindfulness skill application in daily activity.
- MW: Participants will meet at a designated mall location once a week for 2-hour walk.
- WD: Participants will meet at the National Institutes of Health for weekly weight-loss
discussion.
- For the third and fourth visits, participants will receive the same procedures as those
used in the second visit. These visits will occur at the end of the 12-week activity
period and at a 3-month follow up visit.
Objective: The objective of this protocol is to pilot test the efficacy of a Mindful Tai Chi
(MTC) intervention as an integrative approach to facilitate durable weight loss and
well-being among sedentary obese and overweight individuals. Numerous interventions for
obesity are available but the results are temporary, with most individuals returning to or
exceeding their baseline weights. Contrasting with conventional emphases on quantitative
weight reduction with factual didactics, exercise and diet, this protocol will focus on
enhancing individuals integrative resources utilizing mindfulness principles facilitating
changes in self healthcare behaviors.
MTC is a combined form of Tai Chi and mindfulness meditation. Tai Chi and mindfulness both
have common philosophical underpinnings that address health promotion and well-being. Tai Chi
is a gentle moving meditation that fosters individuals body-mind-spiritual integration
through specific movements. MTC is a systemic intervention with multidimensional effects on
health and well-being that facilitate healthy lifestyle by applying the skill of
non-judgmental awareness on a moment-to-moment daily basis. We hypothesize improvements in
health and well-being variables of the participants.
Study population: Healthy ambulatory volunteers 18 years and older with BMI between 25 and <
40 will be recruited from the greater Washington area. Exclusion criteria include mental or
physical health limitations that impede participation in the treatments or assessment of
outcome variables.
Design: A randomized controlled clinical trial: comparing the MTC group to an active health
education (HE) control group. These groups will participate in the assigned activities in a
90 minute session twice a week for 10 weeks. All groups will be assessed at baseline and upon
completion of the treatments at week 10 and at a 2 month follow-up.
Outcome measures: The primary outcomes are changes in weight and multiple domains of
well-being. BMI and intra-abdominal fat by abdominal ultrasound will measure weight changes.
Physical well-being variables include biomarkers (lipid profile, BP, CRP, Leptin, IL 6, and
A1C), aerobic fitness from VO(2) max measurement with 6 to 10 minutes of a treadmill test,
and telomerase activity in leukocytes. A battery of questionnaires will measure
psychological, cognitive-affective, socio-spiritual and overall well-being. Secondary
outcomes include mindfulness quality and lifestyle indices.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |